Sheeram N Agharkar

Title: Sheeram N Agharkar: Innovator in Antitumor Formulations

Introduction

Sheeram N Agharkar is a notable inventor based in Fayetteville, NY (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable parenteral antitumor agents. With a total of 2 patents, Agharkar's work has the potential to impact cancer treatment significantly.

Latest Patents

Agharkar's latest patents include innovative formulations aimed at enhancing the stability and efficacy of antitumor agents. One of his patents focuses on "Parenteral elsamitrucin formulations," which are stable parenteral antitumor formulations containing elsamitrucin salt, a stabilizer, and a buffer. These formulations can be stored in sealed containers under air or nitrogen headspace. Another significant patent is for "Stabilized solutions of platinum(II) antitumor agents," which involves solutions of carboplatin and other malonato platinum(II) antitumor agents. These solutions are prepared with stabilizing amounts of 1,1-cyclobutanedicarboxylic acid or salt at pH 4-8, inhibiting unacceptable discoloration and precipitation.

Career Highlights

Throughout his career, Agharkar has worked with prominent companies, including Bristol-Myers Squibb Company. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of antitumor formulations.

Collaborations

Agharkar has collaborated with notable colleagues, including Murray A Kaplan and Lawan Phusanti, who is a woman. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Sheeram N Agharkar's contributions to antitumor formulations demonstrate his commitment to improving cancer treatment through innovative solutions. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing patient care.